Radiation-Induced Valvulopathy

Radiation-Induced Valvulopathy

Seilani P¹ ; Alizadeasl A² ; Fumani HK³ ; Moradian M⁴ ; Ghorbanpoor M⁵ ; Parhizgar SE⁵

Show Affiliations

1. Department of Echocardiography, Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran
2. Cardio-Oncology Department and Research Center, Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran
3. Department of Internal Medicine, School of Medicine, Hematology-Oncology and Stem Cell Transplantation Research Center, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran
4. Department of Pediatric Cardiology, Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran
5. Rajaie Cardiovascular, Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran

Source: Iranian Heart Journal Published:2022

Abstract

Cardiovascular disease and cancer are the 2 leading causes of morbidity and mortality in the world. Radiation to the mediastinum is a key component of treatment for numerous neoplasms, including Hodgkin’s lymphoma and breast cancer. Improvements in oncological treatments have increased the number of survivors, some of whom may suffer from adverse cardiovascular effects due to radiation therapy.1, 2 The delayed detrimental cardiovascular effects of such radiotherapy protocols have been recognized more recently, largely due to the latency of presentation.3 Because of the increased life expectancy of these patients, healthcare providers are witnessing an increasing number of long-term side effects of these treatments. Mediastinal radiotherapy is known to cause valvular disease, pericarditis, coronary artery disease, and cardiomyopathy.4 We herein describe a patient who developed radiation-induced valvulopathy with the typical presentation of radiation-induced heart disease 8 years after a left-sided mastectomy and receiving chemotherapy and radiotherapy for breast cancer. © 2022, Iranian Heart Association. All rights reserved.

Style	Citing Format
MLA	Seilani P, et al.. "Radiation-Induced Valvulopathy." Iranian Heart Journal, vol. 23, no. 1, 2022, pp. 228-232.
APA	Seilani P, Alizadeasl A, Fumani HK, Moradian M, Ghorbanpoor M, Parhizgar SE (2022). Radiation-Induced Valvulopathy. Iranian Heart Journal, 23(1), 228-232.
Chicago	Seilani P, Alizadeasl A, Fumani HK, Moradian M, Ghorbanpoor M, Parhizgar SE. "Radiation-Induced Valvulopathy." Iranian Heart Journal 23, no. 1 (2022): 228-232.
Harvard	Seilani P et al. (2022) 'Radiation-Induced Valvulopathy', Iranian Heart Journal, 23(1), pp. 228-232.
Vancouver	Seilani P, Alizadeasl A, Fumani HK, Moradian M, Ghorbanpoor M, Parhizgar SE. Radiation-Induced Valvulopathy. Iranian Heart Journal. 2022;23(1):228-232.
BibTex	@article{ author = {Seilani P and Alizadeasl A and Fumani HK and Moradian M and Ghorbanpoor M and Parhizgar SE}, title = {Radiation-Induced Valvulopathy}, journal = {Iranian Heart Journal}, volume = {23}, number = {1}, pages = {228-232}, year = {2022} }
RIS	TY - JOUR AU - Seilani P AU - Alizadeasl A AU - Fumani HK AU - Moradian M AU - Ghorbanpoor M AU - Parhizgar SE TI - Radiation-Induced Valvulopathy JO - Iranian Heart Journal VL - 23 IS - 1 SP - 228 EP - 232 PY - 2022 ER -

Science Communicator Platform

Authors

Authors Affiliations

Abstract